C7A-35460-44753
4 vaccinations
17 coded responses
40 check-ins
17 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 953 / CA
- Registered
- 2021-03-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Registered dependents
34L-87716-93312
Child or adolescent in my care · Female · 2021-11-23
EZU-33440-19034
Child or adolescent in my care · Male · 2021-11-23
Timeline
-
2021-03-06
Dose 1 — Pfizer-BioNTech
-
2021-03-27
Dose 2 — Pfizer-BioNTech
-
2021-03-28
Registered in v-safe
-
2021-03-28
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy, Tenderness — Feeling: Fair · Site: Pain · Fever · Chills, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Left clavicular lymphadenopathy with tendernessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-29
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy, Tenderness — Feeling: Fair · Site: Pain · Fever · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Left supraclavicular lymphadenopathy with tendernessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-30
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy, Tenderness — Feeling: Good · DiarrheaFree text: Left supraclavicular lymphadenopathy with improved tendernessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-31
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy, Tenderness — Feeling: GoodFree text: Continued improvement of left supraclavicular lymphadenopathy with improving tendernessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-01
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: Improving left supraclavicular lymphadenopathy with no tendernessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-02
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: Improving left supraclavicular lymphadenopathy with no tendernessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-03
Survey response — day 7, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: 2 cm left supraclavicular lymphadenopathy without tendernessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-11
- 2021-04-17
- 2021-04-25
- 2021-05-02
- 2021-05-08
- 2021-06-26
- 2021-09-26
-
2021-11-21
Dose 3 — Pfizer-BioNTech
-
2021-11-23
Survey response — days 1–6 daily, dose 3MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Axilla and subclavicular lymphadenopathy with tendernessMedDRA releases: 2024-11 · check-in free text available
-
2021-11-24
Survey response — days 1–6 daily, dose 3MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Fair · Site: Pain, Swelling · Fever · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Axilla and subclavicular lymphadenopathy and tendernessMedDRA releases: 2024-11 · check-in free text available
-
2021-11-25
Survey response — days 1–6 daily, dose 3MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Fair · Site: Swelling · Fatigue or tirednessFree text: Subclavicular & Axilla lymphadenopathy with tendernessMedDRA releases: 2024-11 · check-in free text available
-
2021-11-27
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: GoodFree text: Mild subclavicular lymphadenopathy with no tendernessMedDRA releases: 2024-11 · check-in free text available
- 2021-11-28
- 2021-12-05
- 2021-12-14
- 2021-12-19
- 2021-12-26
- 2022-01-02
- 2022-02-20
- 2022-05-22
-
2022-11-12
Dose 4 — Pfizer-BioNTech
- 2022-11-12
-
2022-11-13
Survey response — days 1–6 daily, dose 4MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Fair · Site: Pain · Fever · Chills, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Lymphadenopathy with mild tendernessMedDRA releases: 2024-11 · check-in free text available
-
2022-11-14
Survey response — days 1–6 daily, dose 4MedDRA: Lymphadenopathy, Tenderness — Feeling: GoodFree text: Axillary lymphadenopathy with moderate tenderness and subclavicular lymphadenopathy without tendernessMedDRA releases: 2024-11 · check-in free text available
-
2022-11-15
Survey response — days 1–6 daily, dose 4MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good · FeverFree text: Axillary lymphadenopathy with mod tenderness and subclavicular lymphadenopathy without tendernessMedDRA releases: 2024-11 · check-in free text available
-
2022-11-17
Survey response — days 1–6 daily, dose 4MedDRA: Lymphadenopathy — Feeling: GoodFree text: Subclavicular lymphadenopathy without tenderness and Axillary lymphadenopathy without tendernessMedDRA releases: 2024-11 · check-in free text available
-
2022-11-18
Survey response — days 1–6 daily, dose 4MedDRA: Lymphadenopathy — Feeling: GoodFree text: Subclavicular lymphadenopathy without tendernessMedDRA releases: 2024-11 · check-in free text available
-
2022-11-19
Survey response — day 7, dose 4MedDRA: Lymphadenopathy — Feeling: GoodFree text: Supraclavicular lymphadenopathy without tendernessMedDRA releases: 2024-11 · check-in free text available
- 2022-11-26
- 2022-12-03
- 2022-12-10
- 2022-12-18
- 2022-12-24
- 2023-02-12
- 2023-05-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-06 | Pfizer-BioNTech | |
| 2 | 2021-03-27 | Pfizer-BioNTech | |
| 3 | 2021-11-21 | Pfizer-BioNTech | No |
| 4 | 2022-11-12 | Pfizer-BioNTech | No |
Free text
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): Left clavicular lymphadenopathy with tenderness
Systemic reaction (other): Left supraclavicular lymphadenopathy with tenderness
Systemic reaction (other): Left supraclavicular lymphadenopathy with improved tenderness
Systemic reaction (other): Continued improvement of left supraclavicular lymphadenopathy with improving tenderness
Systemic reaction (other): Improving left supraclavicular lymphadenopathy with no tenderness
Systemic reaction (other): Improving left supraclavicular lymphadenopathy with no tenderness
Release 6 — day 7, dose 2
Systemic reaction (other): 2 cm left supraclavicular lymphadenopathy without tenderness
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Axilla and subclavicular lymphadenopathy with tenderness
Systemic reaction (other): Axilla and subclavicular lymphadenopathy and tenderness
Systemic reaction (other): Subclavicular & Axilla lymphadenopathy with tenderness
Systemic reaction (other): Mild subclavicular lymphadenopathy with no tenderness
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Lymphadenopathy with mild tenderness
Systemic reaction (other): Axillary lymphadenopathy with moderate tenderness and subclavicular lymphadenopathy without tenderness
Systemic reaction (other): Axillary lymphadenopathy with mod tenderness and subclavicular lymphadenopathy without tenderness
Systemic reaction (other): Subclavicular lymphadenopathy without tenderness and Axillary lymphadenopathy without tenderness
Systemic reaction (other): Subclavicular lymphadenopathy without tenderness
Release 12 — day 7, dose 4
Systemic reaction (other): Supraclavicular lymphadenopathy without tenderness
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Lymph node pain | · | · | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
| SRO | Tenderness | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release